Cargando…
An S1-Nanoparticle Vaccine Protects against SARS-CoV-2 Challenge in K18-hACE2 Mice
Autores principales: | van Oosten, Linda, Yan, Kexin, Rawle, Daniel J., Le, Thuy T., Altenburg, Jort J., Fougeroux, Cyrielle, Goksøyr, Louise, Adriaan de Jongh, Willem, Nielsen, Morten A., Sander, Adam F., Pijlman, Gorben P., Suhrbier, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327679/ https://www.ncbi.nlm.nih.gov/pubmed/35766489 http://dx.doi.org/10.1128/jvi.00844-22 |
Ejemplares similares
-
Warmer ambient air temperatures reduce nasal turbinate and brain infection, but increase lung inflammation in the K18-hACE2 mouse model of COVID-19
por: Dumenil, Troy, et al.
Publicado: (2023) -
Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants
por: van Oosten, Linda, et al.
Publicado: (2021) -
Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2
por: Yan, Kexin, et al.
Publicado: (2022) -
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
por: Carossino, Mariano, et al.
Publicado: (2022) -
ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions
por: Rawle, Daniel J., et al.
Publicado: (2021)